Loading clinical trials...
Loading clinical trials...
Clinical Efficacy and Long-term Outcomes of Allograft Versus Stented Biological Prosthesis for Primary Tricuspid Valve Disease
Conditions
Interventions
tricuspid valve replacement
Locations
1
Russia
Department of Cardiac Surgery
Chelyabinsk, Russia
Start Date
January 14, 2016
Primary Completion Date
December 14, 2024
Completion Date
June 14, 2025
Last Updated
September 19, 2024
NCT07333495
NCT05797519
NCT05742906
NCT06137807
NCT04770012
NCT06406777
Lead Sponsor
Chelyabinsk Regional Clinical Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions